These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19708279)

  • 1. [Choline alphoscerate (ceretone) in the treatment of patients with chronic cerebral ischemia].
    Stulin ID; Musin RS; Solonskiĭ DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):87-9. PubMed ID: 19708279
    [No Abstract]   [Full Text] [Related]  

  • 2. [The domestic drug cereton in the treatment of patients in the acute period of ischemic stroke].
    Shmyrev VI; Kryzhanovskiĭ SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):53-6. PubMed ID: 19253468
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders].
    Levin OS; Batukaeva LA; Anikina MA; Iunishchenko NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):42-6. PubMed ID: 20032953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of cereton in ischemic stroke].
    Maslova NN; Pysina AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 23():21-2. PubMed ID: 19431273
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phezam in combined therapy of ischemic stroke].
    Arabkhanova MA; Pyshkina LI; Kabanov AA; Kolesnikova TI; Iasamanova AN; Martynov MIu; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(2):24-6. PubMed ID: 18646379
    [No Abstract]   [Full Text] [Related]  

  • 6. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of galidor in therapy of chronic brain ischemia].
    Boĭko AN; Kamchatnov PR; Izmailov AM; Gaponova OV; Kabanov AA; Batysheva TT
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():45-50. PubMed ID: 16447553
    [No Abstract]   [Full Text] [Related]  

  • 8. Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agent.
    Traini E; Bramanti V; Amenta F
    Curr Alzheimer Res; 2013 Dec; 10(10):1070-9. PubMed ID: 24156263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Alzheimers Dis; 2014; 42 Suppl 3():S281-8. PubMed ID: 24898643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative electroencephalography changes in patients with mild cognitive impairment after choline alphoscerate administration.
    Han SH; Chul Youn Y
    J Clin Neurosci; 2022 Aug; 102():42-48. PubMed ID: 35714391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of cereton in patients with chronic brain ischemia and moderate cognitive impairment].
    Pizova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):78-83. PubMed ID: 25726784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An experience of intra-arterial thrombolytic therapy of ischemic stroke in Uzbek republic center of emergency care].
    Gafurov BG; Zakhidov AIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():28-31. PubMed ID: 16447550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
    Parnetti L; Amenta F; Gallai V
    Mech Ageing Dev; 2001 Nov; 122(16):2041-55. PubMed ID: 11589921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of cereton in the acute period of ischemic stroke].
    Ismagilov MF; Vasilevskaia OV; Gaĭfutdinov RT; Strakhova TM; Kuz'mina IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):35-6. PubMed ID: 19365389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of choline alfoscerate effectiveness in chronic ocular ischemic syndrome].
    Kamilov KМ; Kasimova MS; Makhkamova DК
    Vestn Oftalmol; 2016; 132(2):73-76. PubMed ID: 27213801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia].
    Vaizova OE; Vengerovskiĭ AI; Alifirova VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():46-50. PubMed ID: 18196635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascular parkinsonism].
    Zhuchenko TD; Veĭn AM; Golubev VL; Shtul'man DR; Shvareva IS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(4):62-5. PubMed ID: 9606903
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic correction of mild cognitive impairment in patients with chronic cerebral ischemia].
    Odinak MM; Kashin AV; Ememlin AIu; Lupanov IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):25-30. PubMed ID: 23739499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary evaluation of risk and effectiveness of early choline alphoscerate treatment in craniocerebral injury].
    Mandat T; Wilk A; Manowiec R; Koziarski A; Zieliński G; Podgórski JK
    Neurol Neurochir Pol; 2003; 37(6):1231-8. PubMed ID: 15174236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with gliatilin treatment of patients with intracranial neoplasia].
    Kondrat'ev AN; Lesina SS; Kondrat'eva EA; Nazarov PV
    Vopr Onkol; 2006; 52(2):203-4. PubMed ID: 17195650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.